Public expenditure in the area of drug-demand reduction

Series type: Selected issues

Summary

This Selected issue examines direct public expenditure in the field of drug demand reduction incurred in 1999 in the 15 EU Member States and Norway. Although data are still limited in this area, the EMCDDA estimates that expenditure amounted to at least of € 2.3 billion, although the actual figure could be considerably higher. When comparing drug demand reduction expenditure in prevention and treatment, prevention is reported to receive a much smaller percentage of the funds.

Table of contents

  • Expenditure in drug-demand reduction
  • Repartition of expenditure
  • Final considerations
Pages: 
5
Price: 
free
ISBN: 
92-9168-159-8
Catalog Number: 
TDAC03001ENC

Order this publication from the EU Bookshop >>

Loading